
August 2024; papers of the month
The UK REBOA trial left many with doubts over its utility for trauma patients in ED. The time from injury to its use was around 90 minutes and the trial was stopped when it didn't reduce and maybe even increased mortality compared to standard care alone.
But what effect does REBOA have when used prehospitally and how feasible is it? Our first paper, from London HEMS, looks at this and gives a fascinating insight into it's use and the physiological response seen with it.
We've recently looked at dual sequential defibrillation for refractory VF with the DOSE-VF trial. Our second paper this…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.